Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP8396
28 mars 2023 04h54 HE
|
Zealand Pharma
Company announcement – No. 7 / 2023 Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP8396 Dose-dependent body weight reductions of up to a mean of...
Zealand Pharma to Host Conference Call on March 2, 2023 at 2 pm CET (8 am ET) to Present Full Year Results for 2022
24 févr. 2023 01h00 HE
|
Zealand Pharma
Press release – No. 1 / 2023 Zealand Pharma to Host Conference Call on March 2, 2023 at 2 pm CET (8 am ET) to Present Full Year Results for 2022 Copenhagen, Denmark February...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
02 déc. 2022 12h05 HE
|
Zealand Pharma
Company announcement – No. 56/ 2022 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Zealand Pharma grants sign-on warrants and performance stock units under the employee warrant program and management long-term incentive program
02 déc. 2022 12h00 HE
|
Zealand Pharma
Company announcement – No. 55/ 2022 Zealand Pharma grants sign-on warrants and performance stock units under the employee warrant program and management long-term incentive program ...
Total number of shares and voting rights in Zealand Pharma at November 30, 2022
30 nov. 2022 11h05 HE
|
Zealand Pharma
Company announcement – No. 54 / 2022 Total number of shares and voting rights in Zealand Pharma at November 30, 2022 Copenhagen, Denmark and Boston, MA, U.S. November 30, 2022 – Zealand Pharma A/S...
Zealand Pharma Announces Financial Results for the First Nine Months of 2022
10 nov. 2022 09h00 HE
|
Zealand Pharma
Company announcement No. 51 / 2022 Zealand Pharma Announces Financial Results for the First Nine Months of 2022 Copenhagen, Denmark November 10, 2022 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no....
Total number of shares and voting rights in Zealand Pharma at October 31, 2022
31 oct. 2022 12h05 HE
|
Zealand Pharma
Company announcement – No. 48 / 2022 Total number of shares and voting rights in Zealand Pharma at October 31, 2022 Copenhagen, Denmark and Boston, MA, U.S. October 31, 2022 – Zealand Pharma...
Zealand Pharma major shareholder announcement: Polar Capital
11 oct. 2022 11h05 HE
|
Zealand Pharma
Company announcement – No. 47 / 2022 Zealand Pharma major shareholder announcement: Polar Capital Copenhagen, Denmark and Boston, MA, 11 October 2022 – Zealand Pharma A/S (“Zealand”)...
Zealand Pharma major shareholder announcement: Van Herk Investments
10 oct. 2022 11h12 HE
|
Zealand Pharma
Company announcement – No. 46 / 2022 Zealand Pharma major shareholder announcement: Van Herk Investments Copenhagen, Denmark and Boston, MA, 10 October 2022 – Zealand Pharma A/S...
Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares
04 oct. 2022 11h05 HE
|
Zealand Pharma
Company announcement – No. 43 / 2022 Zealand Pharma announces directed issue and private placement of approximately 4.5m new shares NOT FOR RELEASE, PUBLICATION OR...